Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Bulletin Du Cancer|March 31, 2015
[Management of side-effects of targeted therapies in renal cancer: cardiovascular side-effects]Stéphane Ederhy, Brigitte Duclos, Hakim Mahammedi, et al.Bulletin Du Cancer|March 30, 2004
[Saccharomyces cerevisiae: an efficient tool and model system for anticancer research]Jean-Emmanuel Kurtz, Patrick Dufour, Brigitte Duclos, et al.Critical Reviews in Oncology/Hematology|March 26, 2013
mTOR inhibitors in advanced renal cell carcinomas: from biology to clinical practicePhilippe Barthélémy, Benjamin Hoch, Christine Chevreau, et al.Sarcoma|June 4, 2008
Diffuse primary angiosarcoma of the pleura: a case report and review of the literatureJean-Emmanuel Kurtz, Sebastian Serra, Brigitte Duclos, et al.Anticancer Research|November 27, 2008
Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literatureIrène Asmane, Valère Litique, Steve Heymann, et al.Journal of Oncology|May 11, 2010
Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-upStefano C H Kim, Shanti Natarajan-Ame, Bruno Lioure, et al.Oncology|May 18, 2011
New strategies for medical management of castration-resistant prostate cancerIrène Asmane, Jocelyn Céraline, Brigitte Duclos, et al.Human Mutation|October 16, 2009
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell lineGemma Marcias, Eva Erdmann, Gaëlle Lapouge, et al.International Journal of Cancer|November 18, 2003
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancerJocelyn Céraline, Marion D Cruchant, Eva Erdmann, et al.European Journal of Endocrinology|January 22, 2003
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancerJocelyn Céraline, Eva Erdmann, Philippe Erbs, et al.Pageof 2